VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Emerson Electric Co. vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Emerson Electric Co.
EMR · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Emerson Electric Co.'s moat claims, evidence, and risks.
View EMR analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Emerson Electric Co. leads (70 / 100 vs 65 / 100 for Novartis AG).
- Segment focus: Emerson Electric Co. has 6 segments (24.2% in Final Control); Novartis AG has 5 segments (29.3% in Oncology).
- Moat breadth: Emerson Electric Co. has 10 moat types across 4 domains; Novartis AG has 4 across 3.
Primary market context
Emerson Electric Co.
Final Control
Industrial control valves, isolation/shutoff valves, pressure relief & safety valves, actuators and regulators
Global
Process & hybrid manufacturers
Automation components supplier
24.2%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
Emerson Electric Co. strengths
Novartis AG strengths
Segment mix
Emerson Electric Co. segments
Full profile >Final Control
Oligopoly
Measurement & Analytical
Oligopoly
Discrete Automation
Competitive
Safety & Productivity
Competitive
Control Systems & Software
Oligopoly
Test & Measurement
Competitive
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.